Interventional (Clinical Trial)

A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)

For more details on the Vigil Neuroscience VGL101 clinical trial visit the Ignite website: Ignite Study - ALSP Study.

Visit clinicaltrials.gov